Site icon pharmaceutical daily

FDA Compliant Handling of Out-of-Trend Results in Pharmaceutical Quality Control Webinar – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “FDA Compliant Handling of Out-of-Trend Results in Pharmaceutical Quality Control” webinar has been added to ResearchAndMarkets.com’s offering.

This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.

FDA’s guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations.

The guide states: `Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend`. Managing OOT results also helps to avoid time consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.

Key Topics Covered:

Who Should Attend:

For more information about this webinar visit https://www.researchandmarkets.com/r/jio2fj

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version